Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older us cohort: The atherosclerosis risk in communities study cohort

Michael D. Miedema; Faye L. Lopez; Michael J. Blaha; Salim S. Virani; Josef Coresh; Christie M. Ballantyne; Aaron R. Folsom

doi:10.1001/jamainternmed.2014.6288

Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older us cohort: The atherosclerosis risk in communities study cohort

Michael D. Miedema
, Faye L. Lopez
, Michael J. Blaha
, Salim S. Virani
, Josef Coresh
, Christie M. Ballantyne
, Aaron R. Folsom

Epidemiology & Community Health

Research output: Contribution to journal › Letter › peer-review

22 Scopus citations

Original language	English (US)
Pages (from-to)	138-140
Number of pages	3
Journal	JAMA Internal Medicine
Volume	175
Issue number	1
DOIs	https://doi.org/10.1001/jamainternmed.2014.6288
State	Published - Jan 1 2015

Publisher link

10.1001/jamainternmed.2014.6288

Find It

Find It at U of M Libraries

Cite this

Miedema, M. D., Lopez, F. L., Blaha, M. J., Virani, S. S., Coresh, J., Ballantyne, C. M., & Folsom, A. R. (2015). Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older us cohort: The atherosclerosis risk in communities study cohort. JAMA Internal Medicine, 175(1), 138-140. https://doi.org/10.1001/jamainternmed.2014.6288

Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older us cohort: The atherosclerosis risk in communities study cohort. / Miedema, Michael D.; Lopez, Faye L.; Blaha, Michael J. et al.
In: JAMA Internal Medicine, Vol. 175, No. 1, 01.01.2015, p. 138-140.

Research output: Contribution to journal › Letter › peer-review

Miedema, MD, Lopez, FL, Blaha, MJ, Virani, SS, Coresh, J, Ballantyne, CM & Folsom, AR 2015, 'Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older us cohort: The atherosclerosis risk in communities study cohort', JAMA Internal Medicine, vol. 175, no. 1, pp. 138-140. https://doi.org/10.1001/jamainternmed.2014.6288

@article{29ae562e4cc44d4fb131efb90895145e,

title = "Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older us cohort: The atherosclerosis risk in communities study cohort",

author = "Miedema, \{Michael D.\} and Lopez, \{Faye L.\} and Blaha, \{Michael J.\} and Virani, \{Salim S.\} and Josef Coresh and Ballantyne, \{Christie M.\} and Folsom, \{Aaron R.\}",

year = "2015",

month = jan,

day = "1",

doi = "10.1001/jamainternmed.2014.6288",

language = "English (US)",

volume = "175",

pages = "138--140",

journal = "JAMA Internal Medicine",

issn = "2168-6106",

publisher = "American Medical Association",

number = "1",

}

TY - JOUR

T1 - Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older us cohort

T2 - The atherosclerosis risk in communities study cohort

AU - Miedema, Michael D.

AU - Lopez, Faye L.

AU - Blaha, Michael J.

AU - Virani, Salim S.

AU - Coresh, Josef

AU - Ballantyne, Christie M.

AU - Folsom, Aaron R.

PY - 2015/1/1

Y1 - 2015/1/1

UR - https://www.scopus.com/pages/publications/84920593746

UR - https://www.scopus.com/pages/publications/84920593746#tab=citedBy

U2 - 10.1001/jamainternmed.2014.6288

DO - 10.1001/jamainternmed.2014.6288

M3 - Letter

C2 - 25401375

AN - SCOPUS:84920593746

SN - 2168-6106

VL - 175

SP - 138

EP - 140

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

IS - 1

ER -

Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older us cohort: The atherosclerosis risk in communities study cohort

Publisher link

Find It

Other files and links

Cite this